These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 29700923

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: A population-based retrospective cohort study.
    Verma AA, Khuu W, Tadrous M, Gomes T, Mamdani MM.
    PLoS Med; 2018 Jun; 15(6):e1002584. PubMed ID: 29889841
    [Abstract] [Full Text] [Related]

  • 4. Modifications in drug adherence after switch to fixed-dose combination of perindopril/amlodipine in clinical practice. Results of a large-scale Italian experience. The amlodipine-perindopril in real settings (AMPERES) study.
    Degli Esposti L, Perrone V, Veronesi C, Gambera M, Nati G, Perone F, Tagliabue PF, Buda S, Borghi C.
    Curr Med Res Opin; 2018 Sep; 34(9):1571-1577. PubMed ID: 29376432
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of Combination Therapy on Adherence Among US Patients Initiating Therapy for Hypertension: a Cohort Study.
    Lauffenburger JC, Landon JE, Fischer MA.
    J Gen Intern Med; 2017 Jun; 32(6):619-625. PubMed ID: 28050754
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Medication adherence with the fixed combination of ramipril and amlodipine].
    Simonyi G, Ferenci T.
    Orv Hetil; 2014 Nov 23; 155(47):1882-8. PubMed ID: 25403283
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antihypertensive Medication Regimens Used by US Adults With Hypertension and the Potential for Fixed-Dose Combination Products: The National Health and Nutrition Examination Surveys 2015 to 2020.
    Derington CG, Bress AP, Herrick JS, Jacobs JA, Zheutlin AR, Berchie RO, Conroy MB, Cushman WC, King JB.
    J Am Heart Assoc; 2023 Jun 06; 12(11):e028573. PubMed ID: 37158068
    [Abstract] [Full Text] [Related]

  • 15. [One-year persistence of fixed-dose combinations of angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertensive patients].
    Simonyi G, Ferenci T, Finta E, Igaz I, Balogh S, Gasparics R, Medvegy M.
    Orv Hetil; 2019 Mar 06; 160(9):343-348. PubMed ID: 30798621
    [Abstract] [Full Text] [Related]

  • 16. Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension: A Systematic Review and Meta-Analysis.
    Parati G, Kjeldsen S, Coca A, Cushman WC, Wang J.
    Hypertension; 2021 Feb 06; 77(2):692-705. PubMed ID: 33390044
    [Abstract] [Full Text] [Related]

  • 17. Does tablet formulation alone improve adherence and persistence: a comparison of ezetimibe fixed dose combination versus ezetimibe separate pill combination?
    Bartlett LE, Pratt N, Roughead EE.
    Br J Clin Pharmacol; 2017 Jan 06; 83(1):202-210. PubMed ID: 27517705
    [Abstract] [Full Text] [Related]

  • 18. Long-term persistence to mono and combination therapies with angiotensin converting enzymes and angiotensin II receptor blockers in Australia.
    Gadzhanova S, Roughead EE, Bartlett LE.
    Eur J Clin Pharmacol; 2016 Jun 06; 72(6):765-71. PubMed ID: 26961086
    [Abstract] [Full Text] [Related]

  • 19. Benefits of a fixed-dose combination of bisoprolol and amlodipine in the treatment of hypertension in daily practice: results of more than 4000 patients.
    Czarnecka D, Koch EM, Gottwald-Hostalek U.
    Curr Med Res Opin; 2015 May 06; 31(5):875-81. PubMed ID: 25753136
    [Abstract] [Full Text] [Related]

  • 20. Medication compliance and clinical outcomes of fixed-dose combinations vs free combinations of an angiotensin II receptor blocker and a calcium channel blocker in hypertension treatment.
    Tung YC, Huang YC, Wu LS, Chang CJ, Chu PH.
    J Clin Hypertens (Greenwich); 2017 Oct 06; 19(10):983-989. PubMed ID: 28560786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.